Regulus Therapeutics
RGLS
#8387
Rank
โ‚ฌ95.7 M
Marketcap
1,46ย โ‚ฌ
Share price
1.25%
Change (1 day)
-4.77%
Change (1 year)

Regulus Therapeutics (RGLS) - Cash on Hand

Cash on Hand as of June 2024 : โ‚ฌ85.24 M

According to Regulus Therapeutics's latest financial reports the company has โ‚ฌ85.24 M in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Regulus Therapeutics - Cash on Hand chart (from 2011 to 2024)

Cash on Hand by year

Year Cash on Hand Change
2022-12-31โ‚ฌ36.5 M-31.22%
2021-12-31โ‚ฌ53.07 M108.7%
2020-12-31โ‚ฌ25.43 M-16.31%
2019-12-31โ‚ฌ30.38 M149.81%
2018-12-31โ‚ฌ12.16 M-75.7%
2017-12-31โ‚ฌ50.06 M-30.81%
2016-12-31โ‚ฌ72.35 M-30.74%
2015-12-31โ‚ฌ0.10 B-20.38%
2014-12-31โ‚ฌ0.13 B59.02%
2013-12-31โ‚ฌ82.52 M11.18%
2012-12-31โ‚ฌ74.22 M152.7%
2011-12-31โ‚ฌ29.37 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
โ‚ฌ3.40 B 3,895.60%๐Ÿ‡ฌ๐Ÿ‡ง UK
โ‚ฌ6.57 B 7,611.34%๐Ÿ‡ซ๐Ÿ‡ท France
โ‚ฌ1.72 B 1,920.86%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ6.38 B 7,391.00%๐Ÿ‡ฌ๐Ÿ‡ง UK
โ‚ฌ2.36 B 2,678.58%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ25.07 M-70.58%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ6.00 B 6,943.19%๐Ÿ‡บ๐Ÿ‡ธ USA
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA